Serum globulin is an inflammation marker. To date, no evidence regarding the association between serum globulin and disease activity in patients with ulcerative colitis has been reported.
We evaluated the association between serum globulin and endoscopic activity in patients with ulcerative colitis.
Serum globulin was divided into tertiles based on the distribution of study subjects (low globulin, ≤ 2.7 g/dl (reference); moderate globulin, 2.7–3.1 g/dl; and high globulin, > 3.1 g/dl). A single endoscopic specialist evaluated the endoscopic findings, and mucosal healing was based on Mayo endoscopic subscore.
A total of 277 patients with ulcerative colitis were included in the study. Serum globulin was independently positively associated with diminished or absent vascular markings [moderate: adjusted odds ratio (OR) 3.70 (95% confidence interval, CI: 1.82–7.88) and high: adjusted OR 2.40 (95%CI: 1.20–4.94), p for trend = 0.005]. A similar positive association between globulin and erosion was found [high: adjusted OR 2.00 (95%CI: 1.05–3.86)]. Serum globulin was independently inversely associated with mucosal healing [moderate: adjusted OR 0.37 (95%CI: 0.18–0.73) and high: adjusted OR 0.31 (95%CI: 0.14–0.64), p for trend = 0.001] and adjusted partial mucosal healing [moderate: OR 0.51 (95%CI: 0.26–0.98), p for trend = 0.048]. The inverse association between globulin and mucosal healing was significant in the low but not the high C-reactive protein group.
In patients with ulcerative colitis, serum globulin was significantly positively associated with endoscopic activity, and was significantly inversely associated with mucosal healing, especially in the low C-reactive protein group.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Langholz E, Munkholm P, Davidsen M et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107:3–11
Colombel JF, Rutgeerts P, Reinisch W et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011;141:1194–1201
Frøslie KF, Jahnsen J, Moum BA et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007;133:412–422
Lichtenstein GR, Rutgeerts P. Importance of mucosal healing in ulcerative colitis. Inflamm Bowel Dis 2010;16:338–346
Peyrin-Biroulet L, Ferrante M, Magro F et al. Results from the 2nd scientific workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease. J Crohns Colitis 2011;5:477–483
Sandborn WJ, Panés J, Zhang H et al. Correlation between concentrations of fecal calprotectin and outcomes of patients with ulcerative colitis in a phase 2 trial. Gastroenterology 2016;150:96–102
Shah SC, Colombel JF, Sands BE et al. Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2016;14:1245–1255
Colombel JF, D’Hasens G, Lee WJ et al. Outcomes and strategies to support a treat-to-target approach in inflammatory bowel disease: a systematic review. J Crohns Colitis 2020;14:254–266
H. Kenneth Walker. Clinical Methods: The History, Physical and Laboratory Examinations. 3rd ed. Butterworth-Heinemann, London, 1990; 497–499
Feinstein AR, Petersdorf RG. The clinical significance of hyperglobulinemia. Ann Intern Med 1956;44:899–924
Hodgson HJ, Jewell DP. The humoral immune system in inflammatory bowel disease. II. Immunologlobulin levels. Am J Dig Dis 1978;23:123–128
Gryboski JD, Spiro HM. Prognosis in children with Crohn’s disease. Gastroenterology 1978;74:807–817
Ordás L, Eckmann L, Talamini M et al. Ulcerative colitis. Lancet 2012;380:1606–1619
Scheller J, Garbers C, Rose-John S. Interleukin-6 from basic biology to selective blockade of proinflammatory activities. Semin Immunol 2013;26:2–12
Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res 2018;16:26–42
The authors would like to thank Shogo Kitahata, Yu Hashimoto, Masakazu Hanayama, Kazuhiro Tange, Kanako Konishi, Tomoe Kawamura, Hideomi Tomida, Yasunori Yamamoto, Tomo Kogama, Masumi Hino, and Keiko Kikuchi for their support.
Conflict of interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Shiraishi, K., Furukawa, S., Yagi, S. et al. Serum Globulin Is Associated with Endoscopic Findings and Mucosal Healing in Japanese Patients with Ulcerative Colitis. Dig Dis Sci (2021). https://doi.org/10.1007/s10620-021-06834-5
- Ulcerative colitis